In VivoBiopharma Financing Biopharma financings during the third quarter of 2022 totaled $18.1bn from 236 deals. The largest was a $1.39bn royalty sale by Theravance Biopharma to Royalty Pharma , which acqu
Medtech InsightThis month, AbbVie gave iStar Medical an upfront cash payment to continue the development of its glaucoma devices, with the deal also granting AbbVie the option to purchase iSTAR outright for near
In VivoJuly was yet another bumper month for pharma, which saw France-based Sanofi ink a $2bn deal with Skyhawk Therapeutics to develop small molecule drugs for oncology and immunology. (Also see " Sanof
Medtech InsightIV BioHoldings launched three liquid biopsy start-ups aimed at early detection and treatment of cancer and one focusing on metabolic disease: LiquidLung, HepGene and Mammogen. Incorporated in December